Our department supports the work of the Access to COVID-19 Tools (ACT) Accelerator to enhance the development, manufacture, procurement and distribution of COVID-19 treatments for populations in low- and middle-income countries. We also lead the development of approaches for allocation of supplies, a key area of work of ACT-A.